“…Donor site morbidity, immune reactions, case complexity, and cost of procedures have also reinvigorated interest in the long head of the biceps as a source of autologous tissue (Veen, Stevens, and Diercks 2018). A recent retrospective review showed SCR to have a significant additional cost of $3,922 compared to lower trapezius transfer and RTSA (Marigi et al 2022). The subacromial spacer, despite early promising results (Savarese and Romeo 2012;Familiari et al 2021), may not be the best option either, given the cost and recent level I evidence demonstrating its inferiority to debridement alone (Metcalfe et al 2022) and non-superiority when compared to partial repair (Verma et al 2022).…”